JP Morgan Chase
HLTH

JP Morgan Chase’s Cue Health Inc. Common Stock HLTH Stock Holding History

JP Morgan Chase’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-263
Closed -$50 – 7844
2024
Q1 		$50 Buy
263
+5
+2% +$1 ﹤0.01% 7040
2023
Q4 		$42 Sell
258
-29,205
-99% -$9.69K ﹤0.01% 7230
2023
Q3 		$13K Buy
29,463
+4,539
+18% +$2.07K ﹤0.01% 6187
2023
Q2 		$9.2K Sell
24,924
-110,978
-82% -$94.7K ﹤0.01% 6068
2023
Q1 		$248K Sell
135,902
-178,687
-57% -$388K ﹤0.01% 4934
2022
Q4 		$651K Buy
314,589
+48,617
+18% +$154K ﹤0.01% 4348
2022
Q3 		$801K Buy
265,972
+208,356
+362% +$739K ﹤0.01% 4163
2022
Q2 		$184K Buy
57,616
+47,352
+461% +$257K ﹤0.01% 5118
2022
Q1 		$66K Buy
10,264
+4,702
+85% +$42.5K ﹤0.01% 5687
2021
Q4 		$75K Buy
+5,562
New +$61.2K ﹤0.01% 5794

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

JP Morgan Chase's HLTH Position: Q2 2024 in Review

JP Morgan Chase sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 263 shares — an estimated $50 sold.

JP Morgan Chase first reported a position in HLTH in Q4 2021 and held it in 10 quarters. The position peaked at $801K in Q3 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • JP Morgan Chase reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 263 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $50.
  • JP Morgan Chase first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • JP Morgan Chase's Cue Health Inc. Common Stock position peaked at $801K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.